Dr. Clinton Fay Holland, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 601 E Hampden Ave, #410, Englewood, CO 80113 Phone: 303-789-9255 |
Eric Franklin Steen, DPM Podiatrist - Foot & Ankle Surgery Medicare: Accepting Medicare Assignments Practice Location: 3535 S Lafayette St, Suite 110, Englewood, CO 80113 Phone: 720-600-2240 Fax: 720-310-2162 |
George S Gill, DPM Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 401 W Hampden Pl, #260, Englewood, CO 80110 Phone: 303-761-5454 Fax: 303-339-2525 |
Pro Active Podiatry Pc Podiatrist - Foot & Ankle Surgery Medicare: Not Enrolled in Medicare Practice Location: 3535 S Lafayette St, Suite 110, Englewood, CO 80113 Phone: 720-600-2240 Fax: 720-310-2162 |
Denver Foot & Ankle Clinic Pc Podiatrist - Foot & Ankle Surgery Medicare: Not Enrolled in Medicare Practice Location: 401 W Hampden Pl, #260, Englewood, CO 80110 Phone: 303-761-5454 Fax: 303-339-2525 |
Steven M Atkins, D.P.M. Podiatrist - Foot & Ankle Surgery Medicare: Accepting Medicare Assignments Practice Location: 799 E Hampden Ave, Suite 400, Englewood, CO 80113 Phone: 303-789-2663 Fax: 303-788-4871 |
News Archive
The ALS Association announced today that it has awarded 21 new research grants totaling nearly $3.5 million to find treatments and a cure for amyotrophic lateral sclerosis (ALS). The grants were awarded to scientists from laboratories located in nine different states in the United States as well as from the United Kingdom, France, Canada, Switzerland, Israel and Australia.
Cryo-Cell International, Inc. today announced results of a study published this month in the cover article of Stem Cells and Development showing that stem cells found in menstrual blood may one day be a potential source for stem cell therapies in stroke and other central nervous system disorders.
Researchers at The Cancer Institute of New Jersey (CINJ) are enrolling patients for a clinical trial, which aims to evaluate a new drug for breast cancer that has spread (metastatic) in combination with two chemotherapy agents called doxorubicin and cyclophosphamide.
University of Georgia scientists have found that smaller, less toxic amounts of chemotherapy medicine given frequently to mice with human prostate cancer noticeably slowed tumor growth.
In the global war against disease-carrying mosquitoes, scientists have long believed that a single molecular door was the key target for insecticide. This door, however, is closing, giving mosquitoes the upper hand.
› Verified 5 days ago